Retraction: Modification of cysteine residue in P65 subunit of nuclear factor-KB (NF-KB) by Picroliv suppresses NF-KB–regulated gene products and Potentiates apoptosis (Cancer Research (2008) 68 (8861–8870) DOI: 10.1158/0008-5472.CAN-08-1902)

P. Anand, A. B. Kunnumakkara, K. B. Harikumar, K. S. Ahn, V. Badmaev, B. B. Aggarwal

Research output: Contribution to journalComment/debate

Abstract

This article (1) has been retracted at the request of the editors. An institutional investigation determined that the same NF-kB EMSA image was used to represent two different experimental conditions in lanes 2 and 4 in Fig. 4C, and a second NF-kB EMSA image was used in lanes 4 and 5 in Fig. 4D. The original research records related to these figures were not available during the review, and the institution was not able to determine which of the published images were correct. A copy of this Retraction Notice was sent to the last known e-mail addresses for all six authors. Five authors (P. Anand, A.B. Kunnumakkara, K.B. Harikumar, K.S. Ahn, and B.B. Aggarwal) did not agree to the retraction; the remaining author (V. Badmaev) did not respond.

Original languageEnglish
Pages (from-to)5187
Number of pages1
JournalCancer Research
Volume78
Issue number17
DOIs
Publication statusPublished - 1 Sept 2018

Bibliographical note

Publisher Copyright:
© 2018 American Association for Cancer Research.

Fingerprint

Dive into the research topics of 'Retraction: Modification of cysteine residue in P65 subunit of nuclear factor-KB (NF-KB) by Picroliv suppresses NF-KB–regulated gene products and Potentiates apoptosis (Cancer Research (2008) 68 (8861–8870) DOI: 10.1158/0008-5472.CAN-08-1902)'. Together they form a unique fingerprint.

Cite this